Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:

Avenue Therapeutics Inc (ATXI)

Avenue Therapeutics Inc (ATXI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Avenue Therapeutics Reports Third Quarter 2024 Financial Results and Corporate Developments Quiver Quantitative, Inc. - Fri Nov 15, 1:20AM CST

Avenue Therapeutics reports third-quarter results, highlighting progress on drug development for neurologic diseases and financial challenges.Quiver AI SummaryAvenue Therapeutics, Inc. announced its third-quarter...

ATXI : 1.7700 (-1.67%)
Avenue Therapeutics Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights GlobeNewswire - Thu Nov 14, 3:05PM CST

ATXI : 1.7700 (-1.67%)
Avenue Therapeutics to Participate in Maxim Group’s 2024 Healthcare Virtual Summit GlobeNewswire - Wed Oct 9, 7:30AM CDT

FBIO : 1.7200 (-1.15%)
ATXI : 1.7700 (-1.67%)
Wall Street - NYSE Full View
S&P Futures Climb as Investors Weigh Economic Outlook, U.S. Bank Earnings on Tap Barchart - Tue Apr 18, 2023

June S&P 500 futures (ESM23) are trending up +0.34% this morning after three major U.S. benchmark indices ended the regular session higher as market participants digested the latest batch of corporate...

ESM23 : 4,453.35s (+0.61%)
SCHW : 74.31 (+0.94%)
RXDX : 199.92 (+0.09%)
STT : 98.20 (+2.91%)
GOOGL : 191.41 (+1.54%)
JNJ : 144.47 (+0.62%)
BAC : 44.17 (+1.82%)
NFLX : 909.05 (+0.78%)
LMT : 489.02 (+1.95%)
GS : 566.10 (+2.19%)
ERICB.S.DX : 88.650 (-0.37%)
ATXI : 1.7700 (-1.67%)
AnnJi Pharmaceutical Announced A Licensing Agreement With Avenue Therapeutics To Develop And Commercialize AJ201, A First-In-Class Clinical Asset For The Treatment Of Kennedy's Disease PR Newswire - Fri Mar 10, 2023

/PRNewswire/ -- AnnJi Pharmaceutical Co. (AnnJi) has entered into an exclusive license agreement with Avenue Therapeutics Inc. (Avenue, NASDAQ: ATXI) for the...

ATXI : 1.7700 (-1.67%)
Wall Street - shutterstock_2763938
Pre-Market Brief: Stocks Mixed as Key U.S. Payrolls Data Looms Barchart - Fri Oct 7, 2022

December S&P 500 futures (ESZ22) are trending down -0.12% this morning after three major US benchmark indices extended declines for the second successive trading session as investors digested remarks from...

ESZ22 : 3,871.47s (-0.66%)
AMD : 119.21 (+0.28%)
NVDA : 134.70 (+3.08%)
DKNG : 40.35 (+2.41%)
ATXI : 1.7700 (-1.67%)
LEVI : 17.39 (+4.44%)
APRN : 12.99 (-0.08%)
Avenue Therapeutics Announces Outcome of FDA Advisory Committee Meeting on IV Tramadol Globe Newswire - Tue Feb 15, 2022

NEW YORK, Feb. 15, 2022 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (NASDAQ: ATXI) (“Avenue”), a company focused on the development of intravenous...

ATXI : 1.7700 (-1.67%)
Avenue Therapeutics Stock Trading Halted Today Globe Newswire - Tue Feb 15, 2022

FDA Advisory Committee to review IV tramadol New Drug Application...

ATXI : 1.7700 (-1.67%)
Aegis Capital Corp. Acted as Sole Bookrunner on a $2 Million Public Offering of Common Stock for Avenue Therapeutics (NASDAQ: ATXI) AccessWire - Wed Dec 15, 2021

NEW YORK, NY / ACCESSWIRE / December 15, 2021 / Aegis Capital Corp. acted as Sole Bookrunner on a $2 Million Public Offering of Common Stock for Avenue Therapeutics (NASDAQ:ATXI). About Avenue Therapeutics...

ATXI : 1.7700 (-1.67%)
Avenue Therapeutics Announces Closing of Public Offering of Common Stock Globe Newswire - Wed Dec 15, 2021

NEW YORK, Dec. 15, 2021 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (or the “Company”) (NASDAQ: ATXI), a company focused on the development of...

ATXI : 1.7700 (-1.67%)

Barchart Exclusives

Oracle Stock Is Off Its Highs and Could Be Cheap Here Barchart - 59 minutes ago
Oracle Corp. produced higher revenue in Q2 but lower free cash flow and FCF margins. However, ORCL stock is now off its highs and could be undervalued here. Shorting out-of-the-money puts is one way to play it. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot